Metastatic renal cell carcinoma imaging evaluation in the era of anti-angiogenic therapies.
During the last decade, the arsenal of anti-angiogenic (AAG) agents used to treat metastatic renal cell carcinoma (RCC) has grown and revolutionized the treatment of metastatic RCC, leading to improved overall survival compared to conventional chemotherapy and traditional immunotherapy agents. AAG a...
| Publicado en: | Abdominal Radiology Vol. 41; no. 6; pp. 1086 - 1100 |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Jun2016
|
| Acceso en línea: | Ver este registro en EBSCOhost |